Single platform femtosecond laser announced at ESCRS

Article

Bausch + Lomb and Technolas Perfect Vision have announced the release of the VICTUS femtosecond laser platform at this year's ESCRS meeting in Vienna, Austria.

Bausch + Lomb (B+L) and Technolas Perfect Vision (TPV) have announced the release of the VICTUS femtosecond laser platform that supports cataract, refractive and therapeutic procedures at this year’s ESCRS meeting in Vienna, Austria.

CEO and president of the Global Surgical Business for B+L, Robert E. Grant, commented on the news, stating, "Our focus is on bringing innovative products, like the VICTUS platform, to the market that uniquely benefit ophthalmic surgeons and patients. TPV's advanced German engineering and precise manufacturing are perfect complements to B+L's surgical portfolio."

The companies have announced that early clinical data on the platform will be presented at the upcoming AAO meeting in Orlando, Florida, USA and at the Asia-Pacific Association of Cataract and Refractive Surgeons in Seoul, South Korea. Additionally, both companies are currently working with regulatory authorities to secure marketing approvals and will promote the platform globally.

This news comes shortly after the recent announcement that B+L and TPV entered into a definitive agreement with an option for B+L to purchase all outstanding and not owned TPV shares.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.